戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              MALDI imaging mass spectrometry (IMS) of low molecular w
2                                              MALDI mass spectrometry imaging (MSI) enables label-free
3                                              MALDI TIMS-MS separation of lipid isomer standards, incl
4                                              MALDI TOF-TOF analysis suggested covalent (ester bond) a
5                                              MALDI-FTICR mass spectrometry, immunohistochemistry, 3D
6                                              MALDI-HiTES is a broadly applicable tool for the discove
7                                              MALDI-ISD MS protein analysis involves only minimal samp
8                                              MALDI-MSI experiments on spleen tissues from intravenous
9                                              MALDI-MSI methods were developed to enhance the detectio
10                                              MALDI-TOF enzymatic fingerprinting and NMR experiments r
11                                              MALDI-TOF mass spectrometry analyses revealed the oxidat
12                                              MALDI-TOF MS data combined with multivariate analysis, s
13                                              MALDI-TOF MS has shown great utility for rapidly identif
14                                              MALDI-TOF MS is becoming more commonplace for the genus-
15                                              MALDI-TOF MS-based structural analysis of the mutant CWP
16                                              MALDI-TOF profiles demonstrated that Burkholderia lipid
17 itivity, and dynamic range combined in a 21T MALDI FT-ICR MSI experiment enable researchers to visual
18                                         In a MALDI-TOF DUB assay, we quantitate the amount of mono-ub
19 method for arriving at a classification of a MALDI-ToF sample, provided the collagen sequences for ea
20 port use of 2-AA for labeling N-glycans on a MALDI target through nonreductive amination, while simul
21                  Here, we demonstrate that a MALDI quadrupole time-of-flight (Q-TOF) mass spectromete
22 cted 37 cerebrosides in a single run using a MALDI-TOF instrument.
23                                 In addition, MALDI FT-ICR MS of IdeS-digested mAbs allowed isotopic-l
24 on and antigen epitope preservation to allow MALDI MSI to be performed and directly followed by IHC a
25 ofluidic capillary electrophoresis (CE), and MALDI-MS were adopted to resolve positional isomers of s
26 tudy, we have evaluated by HPLC-DAD, DLS and MALDI-TOF a synergic effect of the coexistence of two sa
27  were characterized by SDS-page, RP-HPLC and MALDI-TOF-MS.
28 ate registration of the cell-identifying and MALDI-MS images.
29 s method that combines microarrays, MEF, and MALDI-MS presents an effective platform for lipidomic st
30 the predominant clone identified by MLST and MALDI-TOF, and CR-KP infection was associated with incre
31 ity of compound identification for LC-MS and MALDI imaging lipidomics.
32 xhibiting a high agreement between LC-MS and MALDI-Q-MSI (Pearson correlation r = 0.87).
33  dual-polarity high-resolution MALDI-MSI and MALDI MS(2)I studies.
34 ity in lipid coverages between the NAPA- and MALDI-MSI platforms presents the possibility of selectiv
35 ure was also characterized by FTIR, NMR, and MALDI-TOF.
36 eight <15 kDa) as determined by SDS-PAGE and MALDI-TOF/MS analyses.
37                              Simulations and MALDI spectra of a stroke-damaged rat brain show MS sign
38 ds as well as in vivo, EPR spectroscopy, and MALDI measurements, we show that several MoFe protein sp
39  alternative to conventional targets for any MALDI MS analysis.
40 ctive method for simple postionization in AP-MALDI MSI.
41 rix-assisted laser desorption/ionization (AP-MALDI) setup for high-throughput large-scale sample anal
42 re matrix assisted desorption/ionization (AP-MALDI), several ion sources, operating in a range of geo
43    However, the ultimate limits of liquid AP-MALDI in sample throughput can be conservatively estimat
44 n also be used in combination with liquid AP-MALDI MS.
45  second-generation transmission mode (TM) AP-MALDI imaging platform with in-line plasma postionizatio
46 erformed using a mass spectrometry approach (MALDI-ToF-MS), and the potential bioactivity evaluated b
47 r weight ions is particularly challenging as MALDI matrix clusters are often nominally isobaric with
48     In this study, we developed a cell-based MALDI MS workflow for investigation of OATP2B1 cellular
49 d non-fermented bovine milk were analysed by MALDI-TOF mass spectrometry, and their tryptic digestion
50 43 were isolated, and structural analysis by MALDI-TOF-MS, GC-MS, and 2D NMR revealed that both were
51      The resulting materials are analyzed by MALDI-imaging mass spectrometry (MALDI-IMS) to verify th
52 collected from the capillary and analyzed by MALDI-TOF MS.
53 ulting in a bottom-up proteomics approach by MALDI-TOF mass spectrometry (MS).
54 ccessfully identified directly from broth by MALDI-TOF.
55            The improved chemical coverage by MALDI-2 can also help to improve our understanding of th
56  by NAPA-MS and 62 were uniquely detected by MALDI-MS.
57 incubation, washing, and elution followed by MALDI-MS analysis.
58 imple dilution of milks in water followed by MALDI-TOF MS analyses in the positive linear ion mode an
59                             Results given by MALDI-TOF were compared with the reference methods used
60                  Bacteria were identified by MALDI-TOF, antimicrobial susceptibility testing followed
61  glycoblotting-protocol then investigated by MALDI-TOF/MS.
62 However, robust and accurate quantitation by MALDI-MSI still remains a challenge.
63 oteins observed in infected kidney tissue by MALDI FT-ICR IMS through accurate mass matching.
64 postionisation coupled with MALDI (so-called MALDI-2) to the analysis and imaging of pharmaceutical c
65          We present a protocol that combines MALDI-MS with immunocytochemistry to assay over a thousa
66 mple images corresponding to the most common MALDI matrix (2,5-dihydroxybenzoic acid, DHB) and charac
67 mpared to that of MALDI-MSI using two common MALDI matrices.
68  designed to produce reliable and comparable MALDI-MSI data from single sections and tissue microarra
69  that culturing can be avoided by conducting MALDI-TOF MS on individual bacterial cells.
70     In particular, TOF-SIMS and confirmatory MALDI FT-ICR MS (/MS) analysis permitted the mapping of
71 e detected without the use of a conventional MALDI matrix.
72 orders of magnitude compared to conventional MALDI analysis.
73  from tissue was obtained using conventional MALDI.
74 -steel targets and may be used for different MALDI-TOF MS applications.
75 distributions of z' ions in protein top-down MALDI-ISD FT-ICR mass spectra and show why these distrib
76 tained from kinetic investigations and DSC-, MALDI-TOF-MS-, (1)H NMR-studies of linear polymers prepa
77 on zone produced by P. cichorii, we employed MALDI imaging mass spectrometry (MALDI IMS) and MS/MS mo
78 makes a substantial step toward establishing MALDI-MSI as a fully quantitative validated method.
79 nced lipid ionization through thin-gold-film MALDI-MS.
80 me-of-flight mass spectrometer (timsTOF fleX MALDI-2, Bruker Daltonics).
81  laser desorption ionization-time of flight (MALDI-TOF) analyses following trypsin digestion of the t
82  laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry.
83  laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometry.
84  laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry applications in dual polari
85  laser desorption/ionization time-of-flight (MALDI-TOF) MS analysis of microbial proteins.
86  laser desorption/ionization time-of-flight (MALDI-ToF) spectra.
87  laser desorption ionization/time-of-flight (MALDI/ToF) mass spectrometry and (1)H NMR were used for
88 re, on-tissue derivatization was applied for MALDI-MSI of N-glycans from human laryngeal cancer and o
89 ree sulfhydryl groups in tissue is known for MALDI MSI.
90 hiol-containing metabolites with CHC-Mal for MALDI MSI was also possible when using aged tissue in th
91 d was successfully applied as the matrix for MALDI-TOF mass spectrometry imaging (MSI) for studying t
92 rs the highest mass spectral performance for MALDI MSI experiments, and often reveals molecular featu
93 es were subcultured on blood agar plates for MALDI-TOF analysis.
94 ctrospray ionization (ESI) source, while for MALDI imaging, the exchange was performed in the ion fun
95 to achieve a trustworthy identification from MALDI-TOF MS data, a significant amount of biomass shoul
96 d by extraction of EYFP's molecular ion from MALDI-MS images, automated, whole-image assignment of ce
97 we accomplish by using the heme signals from MALDI-MSI and iron signals from LA-ICP-MSI to overlay th
98 an external control for peptide and N-glycan MALDI-MSI throughout the experiment.
99                                        Here, MALDI MSI at 21T is demonstrated for the first time: mas
100 -transform ion cyclotron resonance (FT-ICR), MALDI mass spectrometry imaging (MSI) to image the distr
101 storage containers and obtained identifiable MALDI-TOF MS collagen fingerprints, all indicative of th
102 rption/ionization mass spectrometry imaging (MALDI MSI) and laser scanning confocal microscopy (LSCM)
103 rption/ionization mass spectrometry imaging (MALDI MSI) is a powerful technique for spatially resolve
104 rption/ionization mass spectrometry imaging (MALDI MSI) is an established tool for the investigation
105 rption ionization mass spectrometry imaging (MALDI MSI) technologies offers a high promise to deeper
106 rption/ionization mass spectrometry imaging (MALDI MSI) workflows with antibody slide arrays is descr
107 rption/ionization mass spectrometry imaging (MALDI MSI)-based study was designed in order to selectiv
108 rption/ionization mass spectrometry imaging (MALDI-MSI) and laser ablation inductively coupled plasma
109 rption/ionization mass spectrometry imaging (MALDI-MSI) experiments were performed on whole brains fr
110 rption/ionization mass spectrometry imaging (MALDI-MSI) has been widely applied to the discovery of p
111 rption/ionization mass spectrometry imaging (MALDI-MSI) is an established tool in drug development, w
112 rption ionization mass spectrometry imaging (MALDI-MSI) is widely used to visualize and analyze the d
113 rption/ionization mass spectrometry imaging (MALDI-MSI) was developed for analysis of N-glycans from
114 rption/ionization-mass spectrometry imaging (MALDI-MSI) within pharmaceutical research.
115 rption/ionization mass spectrometry imaging (MALDI-MSI).
116      Although our PTEN immuno-MRM and immuno-MALDI assays can be considered to be orthogonal as they
117 N in Colo-205 cells by immuno-MRM and immuno-MALDI using 2-PIC and external calibration yielded very
118 total protein) between immuno-MRM and immuno-MALDI.
119 ration: 4.9% for immuno-MRM; 1.1% for immuno-MALDI), without the need for a surrogate matrix or addit
120 nic acids facilitating their anionization in MALDI source).
121 ntly up-regulated in 5-FU-resistant cells in MALDI-TOF analysis.
122 rate and confident assignments of z' ions in MALDI-ISD FT-ICR mass spectra.
123 le simultaneously functioning as a matrix in MALDI-MS glycan analysis.
124 seful for the identification of pathology in MALDI biological samples.
125 ser desorption ionization (MALDI), including MALDI-MS imaging and ion mobility, particularly high-fie
126 spectrometric analysis techniques, including MALDI and various ambient ionization methods.
127                              With increasing MALDI-TOF MS use, CLs are well-advised to adhere strictl
128 the combination of negative and positive ion MALDI FT-ICR MS is a useful tool to improve the characte
129 matrix-assisted laser desorption ionization (MALDI) and electrospray ionization (ESI) for both spatia
130 matrix-assisted laser desorption ionization (MALDI) and other IMS methods through direct IMS analyses
131 matrix-assisted laser desorption ionization (MALDI) imaging and infrared (IR) laser ablation sampling
132 Matrix Assisted Laser Desorption Ionization (MALDI) Imaging and Laser Ablation - Inductively Coupled
133 matrix-assisted laser desorption ionization (MALDI) imaging mass spectrometry (IMS) combined with tim
134 matrix-assisted laser desorption ionization (MALDI) imaging mass spectrometry (IMS).
135 matrix-assisted laser desorption ionization (MALDI) is the method of choice for the molecular imaging
136 matrix-assisted laser desorption ionization (MALDI) techniques.
137 matrix-assisted laser desorption ionization (MALDI), desorption electrospray ionization (DESI) and se
138 matrix assisted laser desorption ionization (MALDI), including MALDI-MS imaging and ion mobility, par
139 matrix-assisted laser desorption ionization (MALDI)-like scenario, leading to the desorption/ionizati
140 matrix-assisted laser desorption ionization (MALDI)] enables the development of highly sensitive and
141 matrix-assisted laser desorption/ionization (MALDI) analyses, and heterologous enzyme production iden
142 matrix-assisted laser desorption/ionization (MALDI) combined with in-source decay (ISD) fragmentation
143 Matrix-assisted laser desorption/ionization (MALDI) imaging mass spectrometry (IMS) allows for direct
144 matrix-assisted laser desorption/ionization (MALDI) imaging mass spectrometry (IMS) of bacterial micr
145 matrix-assisted laser desorption/ionization (MALDI) imaging mass spectrometry in positive ionization
146 Matrix-assisted laser desorption/ionization (MALDI) mass spectrometry imaging (MSI) provides a unique
147 matrix-assisted laser desorption/ionization (MALDI) mass spectrometry imaging (MSI) requires instrume
148 matrix-assisted laser desorption/ionization (MALDI) matrix for spatially resolved lipidomics investig
149 matrix-assisted laser desorption/ionization (MALDI) MS can measure the chemical contents of individua
150 matrix-assisted laser desorption/ionization (MALDI) with 1,4-phenylenedipropionic acid (PDPA) reagent
151 matrix-assisted laser desorption/ionization (MALDI), combined with in-source decay (ISD) fragmentatio
152 matrix-assisted laser desorption/ionization (MALDI).
153 lem by use of laser-induced post-ionization (MALDI-2) and by adapting a t-MALDI-2 ion source to an Or
154 riments revealed that laser post-ionization (MALDI-2) has great potential to overwrite changes in sig
155    Upon use of a 1 kHz postionization laser, MALDI-2 produces a sizable increase in the number of det
156 gher spatial resolution than most metabolite MALDI IMS experiments (20 mum) while maintaining broad c
157        In particular, with current microbial MALDI-MSI methods chemical coverage is strongly limited
158                 The use of negative ion mode MALDI-2-MSI could constitute a valuable tool in glycobio
159 visited the application of negative ion mode MALDI-ISD and found good coverage of the peptide chain t
160 evaluation of positive and negative ion mode MALDI-ISD FT-ICR MS in the m/z range 46-13 500 showed an
161                                    Moreover, MALDI-TOF MSI results were obtained for lipid distributi
162 LC, combined with highly sensitive LC-MS/MS, MALDI-TOF-MS, and exoglycosidase treatments.
163 -assisted laser desorption/ionization-Q-MSI (MALDI-Q-MSI), using a mixture of three isotopically labe
164 al capabilities of BzPy as a multifunctional MALDI-MSI matrix are demonstrated by imaging endogenous
165 lts demonstrate the promising application of MALDI-TOF MS in evaluating the photodynamic effect of ea
166      Collision-induced dissociation (CID) of MALDI-generated ozonide ions (with yields in the several
167 e Classifier, to bacterial classification of MALDI-TOF MS data.
168 tis tissue sections, that the combination of MALDI-2 with the trapped ion mobility spectrometry (TIMS
169                                Comparison of MALDI-TOF-MS spectra of all obtained extracts clearly in
170 The 3D printing allows easy manufacturing of MALDI targets with different dimensions and spot geometr
171 ssues begins within the normal time scale of MALDI MSI sample preparation.
172 ombination with the increased sensitivity of MALDI-2 available in one instrument, the described metho
173 we compare the utility of NAPA-MS to that of MALDI-MS using two common matrices for the analysis of m
174  afforded by NAPA-MSI is compared to that of MALDI-MSI using two common MALDI matrices.
175                                    By use of MALDI-MS imaging (MSI) in combination with PNGase F trea
176        This work demonstrates the utility of MALDI imaging for spatial localization of fungicide in f
177 rk will contribute towards the validation of MALDI MS based methods and deployment in violent crimes
178 structural characterization of mAbs based on MALDI in-source decay (ISD) fragmentation, coupled with
179  that is specifically designed to operate on MALDI peptide imaging data.
180                                 This 2-AA on-MALDI-target glycan derivatization eliminates tedious sa
181                                       The on-MALDI-target sample preparation is a single-step protoco
182  we coupled laser-induced postionization, or MALDI-2, to a trapped ion mobility quadrupole time-of-fl
183 ization-mass spectrometry imaging with PBCs (MALDI-MSI-PBC) as a drug screening platform.
184 ulation of CD11b/CD18 function, we performed MALDI TOF Mass Spectrometry (MS) analyses on CD11b/CD18
185                    In conclusion, performing MALDI-TOF mass spectrometry analyses in oxidizing condit
186 resulting beneficial effects on phospholipid MALDI IMS.
187 er, due to ion suppression by phospholipids, MALDI has limited ability to efficiently ionize and imag
188  combined with laser-induced postionization (MALDI-2) is a recently introduced method for enhanced ma
189  combined with laser-induced postionization (MALDI-2-MSI) to simultaneously visualize the distributio
190 ass spectrometers with laser-postionization (MALDI-2) modules to increase the analytical sensitivity
191 ple preparation with subatmospheric pressure MALDI, we demonstrate that chemical output from groups o
192         The results indicate that 3D printed MALDI targets are comparable to standard MBT BioTargets
193                     Moreover, the 3D printed MALDI targets are disposable, cheap, and easy to produce
194                               The 3D printed MALDI targets were validated by analysis of different ty
195 lide mounting, a nine-step washing protocol, MALDI matrix sublimation and recrystallization.
196                               This prototype MALDI timsTOF instrument is capable of 10 mum spatial re
197 he HT adaptation of the previously published MALDI-TOF-based DUB assay method.
198                    We present a quantitative MALDI-MSI method using two instruments with different ty
199  report on a sensitive and fast quantitative MALDI-MS/MS method used to assess saffron authenticity b
200 described previously for low repetition rate MALDI-2 systems, but now enables substantially enhanced
201       For the isophthalic/maleic acid ratio, MALDI results yielded constantly lower values than (1)H
202 mpared to the previously introduced reactive MALDI matrix benzophenone, 2-benzoylpyridine (BzPy) is i
203 ing the capabilities of BPh as a PB-reactive MALDI matrix to potentially unveil the impact of DB-posi
204                                    Recently, MALDI-TOF MS-based methodologies for bacteria detection/
205                    Furthermore, two reducing MALDI matrices, namely 1,5-diaminonaphthalene and N-phen
206 ent and allows dual-polarity high-resolution MALDI-MSI and MALDI MS(2)I studies.
207 icantly, five micron high-spatial resolution MALDI-MSI revealed that Arabidopsides are localized to t
208                                The resulting MALDI-ISD MS data is complementary to electrospray ioniz
209    Our results indicate that fast and robust MALDI MS cellular assays could emerge as a high-throughp
210 milks based on lipids fingerprint by routine MALDI-TOF mass spectrometry (MS).
211 of the MALDIxin test adapted for the routine MALDI Biotyper Sirius system provides an unbiased, fast,
212                                      Second, MALDI-MSI of kidney tissues was performed to study the s
213 er many spectra are acquired during a single MALDI-MSI experiment or data from independent experiment
214  MALDIxin test for the MALDI Biotyper Sirius MALDI-TOF MS system (Bruker Daltonics).
215 we employed MALDI imaging mass spectrometry (MALDI IMS) and MS/MS molecular networking.
216 ser desorption/ionization mass spectrometry (MALDI MS) is limited for complex mixtures of carbohydrat
217 ser Desorption Ionisation Mass Spectrometry (MALDI MS)-proteomics based method for the reliable detec
218 analyzed by MALDI-imaging mass spectrometry (MALDI-IMS) to verify their identity.
219 ser desorption/ionization mass spectrometry (MALDI-MS) for the rapid identification of cryptic peptid
220 ser desorption/ionization mass spectrometry (MALDI-MS) is an important tool for high-throughput N-gly
221 ser desorption/ionization mass spectrometry (MALDI-MS) to monitor the multistep conversion of the nat
222 ser desorption/ionization mass spectrometry (MALDI-MS), and capillary liquid chromatography-tandem ma
223 ser desorption/ionization-mass spectrometry (MALDI-MS).
224 ionization time of flight mass spectrometry (MALDI-TOF MS) analysis allowing in minutes the identific
225 ionization-time of flight mass spectrometry (MALDI-TOF MS) and automated identification systems as we
226 ionization-time-of-flight mass spectrometry (MALDI-TOF MS) can be applied for the identification of p
227 ionization-time of flight mass spectrometry (MALDI-TOF MS) for yeast isolate identification, real-tim
228 ionization-time of flight mass spectrometry (MALDI-TOF MS) identification and broth microdilution phe
229 ionization-time of flight mass spectrometry (MALDI-TOF MS) in less than 15 min but is not optimized f
230 ionization time-of-flight mass spectrometry (MALDI-TOF MS) is described in this study.
231 ionization-time of flight mass spectrometry (MALDI-TOF MS) or gene sequencing.
232 ionization time-of-flight mass spectrometry (MALDI-TOF MS) plates, termed fast lipid analysis techniq
233 ionization-time of flight mass spectrometry (MALDI-TOF MS) system was able to identify S. delphini to
234 ionization time-of-flight mass spectrometry (MALDI-TOF MS) target plates printed by FDM technology us
235 ionization time of flight mass spectrometry (MALDI-TOF MS) with only 1 muL of sample in a fast (less
236 ionization-time of flight mass spectrometry (MALDI-TOF MS), and 16S rRNA partial genome sequence anal
237 ionization-time of flight mass spectrometry (MALDI-TOF MS), gas chromatography (GC), SDS-PAGE, Toll-l
238 ionization-time of flight mass spectrometry (MALDI-TOF MS), which has a limited capacity to identify
239 ionization-time of flight mass spectrometry (MALDI-TOF MS).
240 ionization time-of-flight mass spectrometry (MALDI-TOF MS).
241 Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS).
242 ionization time-of-flight mass spectrometry (MALDI-TOF MS).
243 ionization-time of flight mass spectrometry (MALDI-TOF) in Central China.
244 ionization time-of-flight mass spectrometry (MALDI-TOF-MS) is the preferred instrumental platform for
245 ionization time-of-flight mass spectrometry (MALDI-TOF-MS).
246 -diamine-6-ethyl moiety by NMR spectroscopy, MALDI-TOF mass spectroscopy, UV-Vis spectroscopy, and ti
247 g different GPL classes observed in standard MALDI-MSI.
248 ding electrospray ionization and solid state MALDI, as well as MS methods using multiplexing by label
249 luding the observation of cyclic structures (MALDI), E/Z isomerism from maleic to fumaric acid, and t
250 d sequence by database search and subsequent MALDI-TOF/TOF analysis.
251 ost-ionization (MALDI-2) and by adapting a t-MALDI-2 ion source to an Orbitrap mass analyzer.
252 try imaging in transmission-mode geometry (t-MALDI-MSI) can provide molecular information with a pixe
253 l studies of fucosylated N-glycans by tandem MALDI mass spectrometry (MS) in the positive ion mode.
254 y (13)C NMR and multidimensional techniques, MALDI/ToF MS provides a straightforward technique that c
255 ates were identified by biochemical testing, MALDI-TOF MS, and 16S rRNA sequence analysis (179 isolat
256                          We demonstrate that MALDI-2 increased the signal intensities for 7 out of th
257  Taken together, these results indicate that MALDI-IMS can readily visualize metabolites made by very
258                         Results suggest that MALDI-TOF MS and multivariate analysis are useful in det
259 lphini to the species level, suggesting that MALDI-TOF MS is the best option for distinguishing membe
260                           This suggests that MALDI/ToF MS is a suitable tool for the semiquantitative
261                                          The MALDI MSI protocol was optimized in terms of fiducial co
262                                          The MALDI source utilizes a Bruker SmartBeam 3-D laser syste
263 eening technologies currently available, the MALDI-TOF DUB assay combines the use of physiological su
264 d by sample preparation, particularly by the MALDI (matrix-assisted laser desorption/ionization) matr
265 ctionalization of unsaturated PLs during the MALDI process via a laser-light driven Paterno-Buchi (PB
266 tion of available charge carriers during the MALDI process.
267  study, we adapted the MALDIxin test for the MALDI Biotyper Sirius MALDI-TOF MS system (Bruker Dalton
268 ure, the beads are directly dispensed on the MALDI-TOF MS target enabling the identification and sens
269                       We have shown that the MALDI timsTOF platform can maintain reasonable data acqu
270          Intra-assay reproducibility of this MALDI MS method was high (CV < 10%), and results agreed
271 ll-associated polysaccharides (CWPS) through MALDI-TOF MS and methylation analysis, we report on thre
272  consistent with bactericidal rates and thus MALDI-TOF MS might be able to replace the LB agar colony
273 re plasma probe from our developmental AP-TM-MALDI stage.
274 achine learning techniques can be applied to MALDI-TOF mass spectral data of drug-treated cells to ob
275 latform offers better uniformity compared to MALDI, and the wider dynamic range offered by NAPA promi
276 ve alkali metal cation adduction relative to MALDI-MS, with the [M + 2Na/K - H](+) species accounting
277 ution between different classes of GPL under MALDI-MSI conditions.
278                                 Here, we use MALDI timsTOF IMS to image low molecular weight metaboli
279  stored in a plastic bag, provided no useful MALDI-TOF MS spectra.
280                                        Using MALDI-2 and StxB-based immunofluorescence microscopy, Gb
281 sitive (DLD-1) colorectal cancer cells using MALDI-MS and LC-MRM-MS.
282 slow-growing organisms in BSCs and not using MALDI-TOF MS for identification until BTAs have been rul
283 -shaped crystals in their solid state, using MALDI-TOF and Raman spectroscopy.
284 for selective detection of free thiols using MALDI MSI.
285  and dog liver tissue to be visualized using MALDI-2, whereas little-to-no signal from tissue was obt
286 identification, that is, NMR, FT-IR, UV-vis, MALDI-TOF spectral data, single crystal X-ray diffractio
287 ned in the mass region above m/z 1000, while MALDI matrix ions generally hamper the detection of smal
288                      Data were acquired with MALDI-MS by rastering each hair individually.
289 f the analyte molecules, suggesting, as with MALDI, the occurrence of complex and yet to be elucidate
290 urified with RP HPLC, and characterized with MALDI-TOF MS and enzyme digestion essays.
291  and chemical treatments in combination with MALDI-TOF MS and MS/MS.
292 tion, WGS showed 99 and 93% concordance with MALDI-TOF MS at the genus and species levels, respective
293 ication of laser-postionisation coupled with MALDI (so-called MALDI-2) to the analysis and imaging of
294 the on-tissue labeling strategy coupled with MALDI-MSI shows great potential to spatially characteriz
295 eferential formation of [M + H](+) ions with MALDI-2 has no obvious correlation with the gas-phase pr
296 uming complex titrations, were measured with MALDI and (1)H NMR and were in good agreement.
297 or drugs, indicating that coupling PBCs with MALDI-MSI has the potential to develop rapid, large-scal
298                     We demonstrate that with MALDI-2 the sensitivity for the detection of molecular [
299  specific GPL classes and analyzed them with MALDI-MSI in positive- and negative-ion modes.
300 f as few as ~50 cells can be visualized with MALDI-IMS.

 
Page Top